Skip to main content

Table 1 Comparison of general characteristics of HIV-infected patients on HAART with and without insulin resistance (IR)

From: Insulin resistance by homeostasis model assessment in HIV-infected patients on highly active antiretroviral therapy: cross-sectional study

General characteristics (n = 219) Total (n = 219) No IR (n = 144) IR (n = 75) PR P
Male, n (%) 147 (67.1) 96 (66.7) 51 (68.0) 1.041 0.844
Age      0.007
   ≤ 35 years, n (%) 95 (43.4) 70 (48.6) 25 (33.3) 1.000 Reference
  36-45 years, n (%) 74 (33.8) 50 (34.7) 24 (32.0) 1.232 0.398
   ≥ 46 years, n (%) 50 (22.8) 24 (16.7) 26 (34.7) 1.976 0.002
Hispanics, n (%) 190 (86.7) 124 (86.1) 66 (88.0) 1.119 0.709
Family history of T2DM, n (%) 51 (23.3) 34 (23.6) 17 (22.7) 0.965 0.877
Cigarrette smoker, n (%) 54 (24.7) 40 (27.8) 14 (18.7) 0.701 0.186
>1 year on HAART, n (%) 167 (76.3) 106 (73.6) 61 (81.3) 1.357 0.249
HAART regimen with PI, n (%) 20 (9.1) 11 (7.6) 9 (12.0) 1.357 0.235
  1. Abbreviations: HAART highly active antiretroviral therapy; IR insulin resistance; PR prevalence ratio; PI protease inhibitor; T2DM type 2 diabetes mellitus